What is the ticker symbol for Innoviva?

Innoviva trades under the ticker INVA on NASDAQ.

What sector does Innoviva operate in?

Innoviva is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze INVA in a portfolio?

PortView shows INVA's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Innoviva (INVA) Stock Analysis

NASDAQHealthcareBiotechnology

$21.02+0.38%

1-year price historyRange $17.57 – $24.24

52-week range$21.02

$17.45$25.15

Track INVA in your portfolio for free · Portfolio tracker

What Innoviva does

Innoviva, Inc. functions as a pharmaceutical company, concentrating on the worldwide creation and marketing of medical treatments. Its current product lineup prominently includes several once-daily combination therapies: RELVAR/BREO ELLIPTA, which integrates vilanterol (a long-acting beta2 agonist, or LABA) with fluticasone furoate (an inhaled corticosteroid, or ICS); ANORO ELLIPTA, a medication that pairs umeclidinium bromide (a long-acting muscarinic antagonist, or LAMA) with vilanterol (LABA); and TRELEGY ELLIPTA, a comprehensive treatment combining an ICS, LAMA, and LABA. The company has forged a key strategic alliance with Sarissa Capital Management LP. Moreover, Innoviva collaborates with Glaxo Group Limited under an agreement focused on the development and commercialization of daily LABA-based products designed to treat chronic obstructive pulmonary disease and asthma. Founded in 1996, the corporation was initially known as Theravance, Inc., before officially changing its name to Innoviva, Inc. in January 2016. Its primary operational base is situated in Burlingame, California.

Key metrics

Market cap

$1.52B

P/E (TTM)

4.57

EPS (TTM)

$4.60

Beta

0.33

Dividend yield

0.00%

Revenue / share

$6.04

50-day avg

$20.99

200-day avg

$21.86

52-week high

$25.15

52-week low

$17.45

CEO

Pavel Raifeld

ETFs linked to INVA

Broad-market and Healthcare sector ETFs an investor holding Innoviva is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how INVA fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze INVA in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Innoviva?: Innoviva trades under the ticker INVA on NASDAQ.
Which exchange is INVA listed on?: INVA is listed on NASDAQ.
What sector does Innoviva operate in?: Innoviva is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze INVA in a portfolio?: PortView shows INVA's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.